What Is a Low AMH Level? How to Read Your Report, Natural Pregnancy & IVF Chances

What counts as a low AMH level?

A low AMH level usually means a result under about 1.0 to 1.1 ng/mL, though the exact cut-off depends on the laboratory and the assay platform used. AMH estimates how many eggs are still in reserve. It does not measure egg quality, and it does not tell you whether you can conceive naturally. It mainly helps predict how your ovaries would respond to fertility stimulation medication.

Your report will say anti-Müllerian hormone, usually shortened to AMH. It is a dimeric glycoprotein hormone produced specifically by the granulosa cells of small resting, preantral, and early antral follicles (2 to 9 mm in diameter) inside your ovaries. Each follicle holds a single egg. Therefore, the concentration of AMH circulating in your bloodstream acts as a biochemical headcount of your remaining ovarian reserve.

Most Indian diagnostic laboratories report AMH in ng/mL (nanograms per milliliter). Some hospital laboratories report in pmol/L (picomoles per liter). To convert ng/mL to pmol/L, multiply the ng/mL value by approximately 7.14 (for example, 1.0 ng/mL equals 7.14 pmol/L).

Read this before you read the table below: These reference bands are a clinical guide, not a personal verdict. There is no single universal AMH scale. Different laboratories utilize different automated assay platforms (such as Beckman Coulter Access, Roche Elecsys, or Abbott Architect), and the exact same blood sample can return moderately different figures depending on the assay chemistry. Your own laboratory report will specify the biological reference interval established for that kit, and that is the standard that applies to your result.

This matters because many online fertility charts publish a rigid classification table and omit this essential caveat. If your test result sits slightly below a line on someone else’s chart, that cutoff may not even apply to your laboratory’s testing method.

Ovarian Reserve Band	AMH Level (ng/mL)	pmol/L Equivalent	Roughly What It Suggests
Very low	Under 0.5 ng/mL	Under 3.6 pmol/L	Substantially reduced reserve. Changes medication dosage and treatment plan.
Low	0.5 to 1.0 ng/mL	3.6 to 7.1 pmol/L	Below typical for age. Commonly flagged for clinical review and proactive timing.
Within usual range	1.0 to 3.5 ng/mL	7.1 to 25.0 pmol/L	Typical reserve for most women of reproductive age.
High	Above 3.5 to 4.0 ng/mL	Above 25.0 pmol/L	Elevated follicle activity, frequently seen in Polycystic Ovary Syndrome (PCOS).

Clinical Context from Ferty9 Specialists: In modern reproductive medicine, AMH is never interpreted in isolation. At Ferty9 fertility centres, our specialists always correlate your AMH blood test with an Antral Follicle Count (AFC) performed via high-resolution transvaginal ultrasound (TVS), alongside baseline Day 2 or Day 3 FSH (follicle-stimulating hormone) and Estradiol (E2) levels. An ultrasound examination directly visualizes the active follicles in both ovaries, providing a complete 360-degree assessment of your reproductive reserve.

How to read your own report number

Most women searching AMH online are not searching for the biochemical term. They are searching for the exact decimal number printed on their laboratory sheet. Here is what different results generally mean, and more importantly, what they do not mean:

AMH around 0.1 ng/mL or below: Very few resting follicles are being detected. This is the range that frightens women most, and it is vital to understand that women in this range have conceived successfully, both naturally and through specialized IVF protocols. It usually means fewer oocytes collected per cycle and requires a transparent clinical conversation regarding cycle strategy or embryo pooling. It does not, by itself, rule out treatment. Our section below on whether any number is too low to try explains the clinical data in detail.

AMH around 0.3 ng/mL: Significantly reduced resting follicle pool. In IVF, this typically indicates fewer mature eggs collected during an egg retrieval cycle. Your fertility doctor may recommend tailored mild stimulation, an antagonist protocol, or cycle pooling to accumulate embryos. It does not mean you have zero eggs. Women achieve healthy pregnancies with results in this range, including unassisted natural conception.

AMH around 0.7 ng/mL: This was the exact clinical cutoff used to define ‘low ovarian reserve’ in the largest prospective study on natural conception. Women in that study with results below 0.7 ng/mL were not less likely to conceive naturally than women with normal reserves. More on that in our section below on natural conception.

AMH around 1.2 ng/mL: Sitting just below or right around the typical laboratory threshold. This is often the point where a fertility specialist starts paying close attention to timing and family planning roadmaps rather than recommending urgent aggressive intervention. It frequently causes far more emotional alarm than is medically warranted.

AMH around 2.5 ng/mL: Comfortably within the normal physiological range for most women of reproductive age.

What none of these numbers tell you: whether your eggs are chromosomally normal, whether you will conceive this month, or exactly how much reproductive time you have. A number is a starting point for an individualized clinical conversation, not the final verdict of one.

Is there an AMH level too low for IVF? (What Recent Clinical Studies Show)

This is the question underneath almost every late-night search that brings women to fertility websites, and modern medical science provides an unambiguous answer.

A comprehensive 2023 systematic review and meta-analysis published in Human Reproduction pooled 32 international clinical studies to evaluate whether serum AMH levels predict the likelihood of a live birth. Across IVF and ICSI cycles, the researchers identified a statistical relationship: higher AMH is associated with a greater number of collected eggs and therefore more opportunities for embryo transfer. However, the study uncovered a far more profound finding for anyone holding a low test result.

No absolute threshold could be identified. In the authors’ explicit words, there was no serum AMH level below which live birth could not be achieved after IVF or ICSI.

The authors went further with a clinical directive that is remarkably direct for peer-reviewed literature: low AMH ‘should not be used as the sole criterion for rejecting IVF treatment, especially in young patients.’

Three essential clinical conclusions follow from this evidence:

A single number should never end your journey: If you have been told that your AMH number alone completely disqualifies you from trying IVF, and other critical factors were ignored, you should seek a thorough second opinion. Your maternal age, menstrual cycle regularity, ultrasound antral follicle count, and partner’s sperm parameters are equally important.

Age matters far more than the number: A 30-year-old woman with an AMH of 0.3 ng/mL and a 42-year-old woman with the same result are in completely different biological situations. Younger women with low AMH have fewer eggs, but a high percentage of those remaining eggs remain genetically healthy and competent for fertilization. The meta-analysis emphasized caution in young patients for this precise reason.

The absence of a cutoff is partly technical: The researchers highlighted that clinical studies utilized varied AMH testing kits and different cut-off thresholds, representing the same laboratory assay variations described earlier under reference ranges. A number that indicates one value on an automated platform does not reflect identical values on another. That is another clinical reason never to treat a single test slip as an absolute barrier.

The same systematic review noted that there remains limited published data to determine whether AMH reliably predicts live birth following IUI (intrauterine insemination) or in couples attempting unassisted natural conception.

What AMH does not tell you (Egg Quantity vs. Egg Quality)

Three clinical concepts are frequently conflated by patients, and this confusion generates unnecessary emotional distress:

AMH does not measure egg quality: AMH reflects the quantity of resting follicles, not their chromosomal integrity. Egg quality is driven primarily by chronological female age. Two women with identical AMH results of 0.6 ng/mL but a ten-year age gap (for example, age 29 versus age 39) have dramatically different probabilities of producing a chromosomally normal (euploid) embryo. This is why a fertility doctor will weigh your age just as heavily as your blood biomarkers.

AMH does not predict your chance of conceiving in a given cycle: Natural conception in any single menstrual cycle depends on successful ovulation, healthy sperm motility and morphology, open fallopian tubes, and optimal uterine receptivity. AMH describes the size of the underlying ovarian reserve, not this month’s ovulatory event.

AMH is not an expiring countdown clock: Your test report represents a static snapshot of where your ovarian reserve sits today. It is not an hourglass running on a fixed mathematical schedule.

Can you get pregnant naturally with low AMH?

For many women, yes. In fact, the medical literature on this question is significantly more reassuring than almost anything published on commercial social media.

The largest prospective study on natural fertility, published in JAMA (Journal of the American Medical Association), evaluated 750 women aged 30 to 44 who were actively trying to conceive and had no prior history of infertility. Women with low AMH, defined as under 0.7 ng/mL, were systematically compared against women with normal AMH levels.

After 12 cycles of trying, 84% of women with low AMH conceived naturally, compared to 75% of women with normal AMH levels. There was no statistically significant difference between the two groups. The researchers concluded that biomarkers of diminished ovarian reserve were not associated with reduced fertility in women attempting natural conception.

Now the clinical boundary, because context is vital:

The women in that JAMA trial had no longstanding history of infertility and had been attempting to conceive for three months or less prior to enrollment. If you have been actively trying for over a year without success, or if you have an existing diagnosis of tubal blockage, severe endometriosis, or male factor subfertility, this study is not describing your exact clinical scenario. AMH was not a predictor of natural conception in women who had not yet encountered biological barriers.

The balanced medical reality: A low AMH level, on its own, in a woman with regular ovulatory cycles and no other reproductive disorder, is not evidence that natural pregnancy will not happen. However, it is also not a reason to wait indefinitely. If you have been trying for 12 months (or 6 months if you are 35 or older), a comprehensive fertility evaluation is strongly recommended.

Does low AMH mean early menopause?

Not on its own. This represents one of the most acute anxieties experienced by women who receive a low result.

Across broad population cohorts, lower AMH levels correlate statistically with reaching natural menopause somewhat earlier. But statistical association across thousands of women is not an exact calendar forecast for an individual patient. An AMH blood test cannot tell you what specific year you will experience menopause, and it is not utilized clinically as a predictive clock.

If your AMH is low but your menstrual periods remain regular, your ovaries are actively releasing an egg each month. Menstrual regularity is a very reassuring clinical sign. Low AMH combined with regular cycles indicates a smaller follicular reserve, not a non-functioning reproductive system.

Two clinical terms you may encounter on medical paperwork, and what they actually mean:

Diminished Ovarian Reserve (DOR): This is a descriptive clinical classification indicating a lower egg headcount than expected for your chronological age. It is not a declaration that your ovaries have failed, and it is not a diagnosis of menopause.

Poor Responder: If you have undergone an IVF cycle, your embryology or clinical notes might mention ‘poor ovarian response’. This is a clinical term describing a narrow reality: your ovaries produced fewer follicles on that specific drug dose and protocol than average. It describes how your follicles responded to one medication regimen. It is not an assessment of your personal worth, and it is not a final verdict on your ability to have a baby.

Causes of low AMH levels: Why does ovarian reserve decline?

Some of these causes can be clinically managed; others cannot. None of them reflect any personal failing on your part:

Chronological Age: The most dominant natural factor. Biological follicular atresia occurs continuously throughout life, accelerating in a woman’s mid-30s.

Genetic Predisposition: Family history plays a significant role. If your mother or sister experienced early menopause or Premature Ovarian Insufficiency (POI), you may naturally have been born with a smaller baseline pool of primordial follicles.

Endometriosis & Ovarian Endometriomas: Particularly when ‘chocolate cysts’ develop within the ovary, inflammatory changes and physical pressure can diminish healthy follicular tissue.

Prior Pelvic or Ovarian Surgery: Any surgical intervention on the ovary, such as cystectomy for ovarian dermoids or endometriomas, can inadvertently excise or cauterize healthy follicular reserve.

Chemotherapy or Pelvic Radiotherapy: Gonadotoxic oncology treatments can induce rapid follicular depletion.

Autoimmune Conditions: Autoimmune thyroiditis (Hashimoto’s disease), Addison’s disease, or systemic lupus erythematosus (SLE) can sometimes involve anti-ovarian antibodies.

Idiopathic (Unexplained): In many women, low AMH occurs with zero identifiable risk factors or family history. ‘Unexplained diminished reserve’ is a recognized clinical finding, not a failure of medical testing.

An important clinical clarification regarding PCOS: Polycystic Ovary Syndrome is almost universally associated with high AMH levels (often > 4.0 ng/mL) due to dozens of small antral follicles. If you have been told you have PCOS yet your AMH is low, that contradictory combination requires specialist re-evaluation rather than assuming one condition explains the other.

Can you increase or raise low AMH levels naturally? (The Medical Truth)

This is the question most patients urgently ask, and ethical reproductive medicine demands a completely honest answer: There is currently no proven medication, dietary regimen, ayurvedic therapy, or supplement that can create new eggs or permanently raise your biological ovarian reserve.

A woman is born with her entire lifetime supply of eggs. As follicles degenerate naturally over time, modern medicine has no proven method to regenerate the primordial pool.

Regarding DHEA (dehydroepiandrosterone), which is widely promoted online for diminished reserve: the clinical evidence remains inconsistent. A comprehensive 2023 systematic review examining DHEA supplementation in women with reduced ovarian reserve found that the sole randomized controlled trial showed no statistically significant improvement in live birth outcomes. The authors concluded that robust clinical evidence is lacking. While some specialists trial DHEA or CoQ10 in specific poor-responder IVF protocols to potentially support mitochondrial energy in existing follicles, they do not rebuild the baseline reserve.

Telling patients that a proprietary diet or supplement will replenish their eggs would be commercially profitable, but medically untrue. What is genuinely worth doing:

Quitting Smoking & Tobacco: Cigarette toxins accelerate follicular destruction. Smoking cessation is one of the few lifestyle interventions with verified protective benefits for remaining reserve.

Managing Underlying Medical Conditions: Treating pelvic endometriosis, balancing thyroid dysfunction, or managing pelvic inflammatory issues.

Conducting a Complete Couple Assessment: Evaluating your partner’s semen parameters, checking your fallopian tube patency, and assessing uterine cavity health rather than obsessing over a single blood biomarker.

Acting on a Realistic Timeline: If you desire biological children or wish to freeze your eggs (oocyte cryopreservation), making that decision proactively rather than postponing it indefinitely.

Note on test fluctuations: Your AMH result can fluctuate slightly between different cycles. A small decimal change (such as 0.7 to 0.9 ng/mL) represents normal physiological variation and assay precision, not a sudden regeneration of your egg supply.

Low AMH and IVF: Protocols, egg retrieval & success rates

This is where an AMH test provides genuine clinical value to a fertility team.

AMH is an excellent predictor of ovarian response to stimulation medication. In an IVF cycle, knowing your AMH enables your doctor to select the right starting dose of gonadotropins (FSH/HMG) and establish a realistic expectation for the number of mature oocytes retrieved. A landmark 2025 individual participant data meta-analysis published in Human Reproduction Update demonstrated that gonadotropin dosing models based on AMH and AFC optimize follicular recruitment while preventing ovarian hyperstimulation.

AMH is a significantly weaker predictor of whether an IVF cycle results in a live birth. A major systematic review in Human Reproduction Update confirmed that AMH has only modest predictive power for live birth once female age is accounted for, explicitly noting that its predictive accuracy for pregnancy is poor.

And as covered earlier in this guide, the 2023 Peigné meta-analysis confirmed that no AMH level exists below which live birth cannot be achieved.

The practical clinical translation: Low AMH changes the treatment protocol, not the ultimate possibility of parenthood. Retrieving fewer eggs per cycle simply prompts reproductive specialists to utilize tailored antagonist protocols, gentle stimulation, or embryo accumulation across cycles.

Low AMH: Common patient myths vs. clinical realities

Because AMH reports cause substantial anxiety, misinformation is rampant. Here is what medical science actually proves versus common misconceptions:

Common Patient Myth	Clinical Reality	Medical Science & Evidence
Myth 1: ‘Low AMH means I am infertile and cannot conceive naturally.’	Reality: AMH reflects follicle quantity, not monthly ovulation. Women with low AMH can and do conceive naturally.	Evidence: In the JAMA 2017 study of 750 women, 84% of women with low AMH conceived naturally within 12 cycles.
Myth 2: ‘Low AMH means all my remaining eggs are defective or poor quality.’	Reality: AMH measures quantity, not chromosomal normality. Egg quality is driven primarily by female age.	Evidence: A 30-year-old with low AMH often has high-quality, genetically competent eggs capable of healthy fertilization.
Myth 3: ‘Miracle supplements or special diets can regrow my egg reserve.’	Reality: Females are born with all the eggs they will ever have. No supplement can replenish depleted follicles.	Evidence: Systematic reviews (2023) confirm that DHEA and herbal remedies show no robust clinical evidence of raising ovarian reserve.
Myth 4: ‘A low AMH report means I am entering immediate menopause.’	Reality: Regular menstrual periods mean you are actively ovulating. Low AMH describes a smaller reserve, not stopped ovaries.	Evidence: AMH cannot predict the exact calendar year of menopause for an individual patient.
Myth 5: ‘IVF clinics will automatically refuse me if my AMH is under 0.5.’	Reality: Low AMH alone should never be the sole reason to deny IVF, particularly in younger women.	Evidence: The 2023 Peigné meta-analysis of 32 studies showed no AMH cutoff below which live birth could not be achieved.

Need Expert Guidance on Your AMH Test Report?A single lab slip does not define your motherhood journey. At Ferty9 Fertility Center, our senior reproductive medicine specialists conduct comprehensive evaluations pairing precision AMH blood testing with high-resolution Antral Follicle Count (AFC) scans. Whether you are planning natural conception, egg freezing, or advanced IVF, we design individualized protocols with zero judgment. Book an in-depth ovarian reserve consultation at your nearest Ferty9 centre today.

Frequently asked questions

Is low AMH reversible?

No proven medical treatment or lifestyle protocol can permanently raise ovarian reserve. AMH can fluctuate slightly between different cycles due to lab assay variations, but this is measurement variability rather than genuine follicle regeneration.

What does an AMH of 0.1 mean?

An AMH of 0.1 ng/mL indicates a very low ovarian reserve. It generally means fewer oocytes will be retrieved during an IVF cycle, and your doctor will discuss whether individualized stimulation or multiple cycles are advisable. Crucially, studies have shown no threshold below which pregnancy is impossible, so a figure this low does not by itself rule out successful treatment.

What does an AMH of 0.5 mean?

An AMH of 0.5 ng/mL indicates a low ovarian reserve and warrants a proactive discussion regarding treatment options and timelines. It does not mean pregnancy cannot occur, and it must be evaluated alongside your age, menstrual regularity, and partner’s semen health.

Can a fertility clinic refuse IVF because of low AMH?

A major 2023 systematic review of 32 studies concluded that low AMH should not be the sole criterion for rejecting IVF, especially in younger women. If your AMH number alone has been cited as a reason to deny care without weighing your age and overall health, seeking a second opinion is strongly recommended.

Can you have low AMH and still have regular menstrual periods?

Yes, this is very common. Regular menstrual cycles indicate that you are ovulating each month. Low AMH describes the size of the underlying reserve pool, not whether your ovaries are actively functioning.

Does low AMH mean I have PCOS?

No. Polycystic Ovary Syndrome is typically characterized by elevated AMH levels (frequently > 3.5 to 4.0 ng/mL). If you have both a PCOS diagnosis and a low AMH result, this warrants dedicated clinical review by a reproductive endocrinologist.

Does a low AMH level increase the risk of miscarriage?

AMH measures egg quantity, not egg quality. Miscarriage is most closely linked to chromosomal abnormalities, which correlate with maternal age rather than follicle count. Low AMH by itself is not established as a direct cause of pregnancy loss.

Is a low AMH level genetic or hereditary?

It can run in families, particularly where there is a maternal history of early menopause or Premature Ovarian Insufficiency (POI). However, many women with low AMH have no identifiable genetic or familial cause.

Can I get pregnant at age 37 with low AMH?

Yes, natural and assisted pregnancies occur routinely at 37 with low AMH. At age 37, maternal age has a greater influence on egg chromosomal normality than the AMH number does. If you have been trying for six months or more at this age, an evaluation is recommended rather than waiting.

How does low AMH affect IVF success rates?

Low AMH primarily influences the quantity of eggs collected during an egg retrieval cycle rather than the viability of individual embryos. Your fertility specialist uses this number to tailor medication dosages and establish realistic expectations for the cycle.

How much does an AMH blood test cost in India?

The cost of an AMH blood test typically ranges from Rs 1,500 to Rs 3,000 depending on the city, hospital, and laboratory assay used. You can check current pricing and book an accredited test directly at Ferty9 centres.

References

Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, Baird DD. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA. 2017;318(14):1367-1376. PMID 29049585.

Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM. The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature. Human Reproduction Update. 2014;20(4):560-570. PMID 24532220.

Peigné M, Bernard V, Dijols L, Creux H, Robin G, Hocké C, Grynberg M, Dewailly D, Sonigo C. Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis. Human Reproduction. 2023;38(9):1789-1806. PMID 37475164.

Schouten N, Wang R, Torrance H, et al. Development and validation of a gonadotropin dose selection model for optimized ovarian stimulation in IVF/ICSI: an individual participant data meta-analysis. Human Reproduction Update. 2025;31(2):116-132. PMID 39707165.

Yuan WS, Abu MA, Ahmad MF, Elias MH, Abdul Karim AK. Effects of Dehydroepiandrosterone (DHEA) Supplementation on Ovarian Cumulus Cells following IVF/ICSI Treatment: A Systematic Review. Life (Basel). 2023;13(6):1237. PMID 37374020.

Gomes MO, Gomes JO, Ananias LF, Lombardi LA, da Silva FS, Espindula AP. Anti-Müllerian hormone as a diagnostic marker of polycystic ovary syndrome: a systematic review with meta-analysis. American Journal of Obstetrics and Gynecology. 2025;232(6):506-523.e7. PMID 39922442.